The approval of TEPOXX in Japan marks another significant milestone in our mission to expand access to this critical ...

Shattuck Labs (STTK) announced a corporate update and highlighted upcoming key milestones anticipated in 2025. “We have made ...

San Diego-based iBio has signed a backloaded agreement with its existing partner AstralBio for a preclinical anti-myostatin ...

A recent study conducted in Japan has shown that chimpanzees perform better at solving complex problems when observed by ...

What does a gazelle think when a member of its herd becomes a lion’s dinner? Questions like these have been very much on the mind of the Spanish philosopher Susana Monsó, whose new book, “Playing ...

An orca that carried her dead calf for 17 days in 2018 seems to be repeating the behavior with a newly deceased baby whale.

While humans share over 95% of their genome with chimpanzees, our brains are far more complex due to differences in gene expression.

On Thursday, the Japan Ministry of Health, Labour and Welfare approved SIGA Technologies (NASDAQ:SIGA) antiviral treatment ...

Regulatory decision marks first approval in Japan of an antiviral for the treatment of orthopoxviruses including smallpox, mpox and cowpoxJapan Biotechno Pharma Co., Ltd. engaged as exclusive distribu ...

Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis ...

Bio advances obesity treatment with IBIO-600, a long-acting anti-myostatin antibody designed for subcutaneous use, targeting ...

TPOXX is approved in the U.S. and Canada for the treatment of smallpox. In the European Union and United Kingdom, marketed as Tecovirimat-SIGA, it is approved for the treatment of smallpox, mpox, ...